A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972.

PubWeight™: 3.71‹?› | Rank: Top 1%

🔗 View Article (PMID 4745236)

Published in Am J Trop Med Hyg on November 01, 1973

Authors

T P Monath, P E Mertens, R Patton, C R Moser, J J Baum, L Pinneo, G W Gary, R E Kissling

Articles citing this

Ebola haemorrhagic fever in Sudan, 1976. Report of a WHO/International Study Team. Bull World Health Organ (1978) 5.82

Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ (1983) 4.81

Genetic diversity among Lassa virus strains. J Virol (2000) 3.00

Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. Emerg Infect Dis (2000) 2.69

Risk maps of Lassa fever in West Africa. PLoS Negl Trop Dis (2009) 2.33

Lassa fever in post-conflict sierra leone. PLoS Negl Trop Dis (2014) 2.23

Pathologic and virologic study of fatal Lassa fever in man. Am J Pathol (1982) 2.14

Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ (1975) 1.86

Replicon system for Lassa virus. J Virol (2004) 1.69

A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. BMJ (1988) 1.51

Lassa fever in Onitsha, East Central State, Nigeria in 1974. Bull World Health Organ (1975) 1.44

Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis (2010) 1.28

Molecular diagnostics for lassa fever at Irrua specialist teaching hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis (2012) 1.27

On the front lines of Lassa fever. Emerg Infect Dis (2004) 1.24

Pathogenesis of Lassa fever. Viruses (2012) 1.23

Experimental Lassa virus infection in the squirrel monkey. Am J Pathol (1975) 1.13

Diagnosis of Lassa fever and the isolation and management of patients. Bull World Health Organ (1975) 1.09

Occupational hazards in hospitals: risk of infection. Br J Ind Med (1987) 1.08

Mapping the zoonotic niche of Lassa fever in Africa. Trans R Soc Trop Med Hyg (2015) 0.98

Using modelling to disentangle the relative contributions of zoonotic and anthroponotic transmission: the case of lassa fever. PLoS Negl Trop Dis (2015) 0.96

A serological survey of Lassa fever in Liberia. Bull World Health Organ (1978) 0.95

Antigenic properties of the arenaviruses. Bull World Health Organ (1975) 0.95

Multifunctional nature of the arenavirus RING finger protein Z. Viruses (2012) 0.92

Arenaviruses. Yale J Biol Med (1975) 0.92

Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever. Clin Vaccine Immunol (2007) 0.91

Prevalence and risk factors of Lassa seropositivity in inhabitants of the forest region of Guinea: a cross-sectional study. PLoS Negl Trop Dis (2009) 0.87

Severe hemorrhagic fever in strain 13/N guinea pigs infected with Lujo virus. PLoS Negl Trop Dis (2012) 0.84

Lassa fever: retrospective diagnosis of two patients seen in Great Britain in 1971. Br Med J (1976) 0.82

Moving interdisciplinary science forward: integrating participatory modelling with mathematical modelling of zoonotic disease in Africa. Infect Dis Poverty (2016) 0.81

Use of the complement fixation (CF) test in Lassa fever surveillance. Evidence for persistent CF antibodies. Bull World Health Organ (1975) 0.81

Effectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid Review. PLoS One (2015) 0.80

The laboratory diagnosis of tropical diseases with special reference to Britain: a review. J Clin Pathol (1974) 0.80

Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism. J Virol (2014) 0.76

Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man. Future Virol (2015) 0.75

In memoriam: Robert Emmons Kissling (1923–2013). Emerg Infect Dis (2014) 0.75

Prevalence of Lassa Virus Disease (LVD) in Nigerian children with fever or fever and convulsions in an endemic area. PLoS Negl Trop Dis (2017) 0.75

Articles by these authors

A waterborne outbreak of cryptosporidiosis in normal hosts. Ann Intern Med (1985) 5.27

Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med (1982) 4.54

Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science (1974) 3.86

The frequency of a Norwalk-like pattern of illness in outbreaks of acute gastroenteritis. Am J Public Health (1982) 3.78

Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75

Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg (1972) 3.44

Inactivation of Norwalk virus in drinking water by chlorine. Appl Environ Microbiol (1985) 3.12

Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet (2001) 3.09

Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. II. Clinical observations and virological studies on selected hospital cases. Am J Trop Med Hyg (1974) 2.95

Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. J Clin Microbiol (1984) 2.95

Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology (1999) 2.72

Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med (1998) 2.70

Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ (1981) 2.36

Lassa fever. Trop Doct (1973) 2.32

A waterborne outbreak of gastroenteritis with secondary person-to-person spread. Association with a viral agent. Lancet (1979) 2.29

Detection of Norwalk virus antibodies and antigen with a biotin-avidin immunoassay. J Clin Microbiol (1985) 2.28

Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol (1986) 2.26

Human monkeypox. Bull World Health Organ (1972) 2.18

Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Virology (1983) 1.98

Agent of disease contracted from green monkeys. Science (1968) 1.98

Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis (1995) 1.97

Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies. Am J Trop Med Hyg (1974) 1.92

Clinical presentation of Lassa fever cases during the hospital epidemic at Zorzor, Liberia, March-April 1972. Am J Trop Med Hyg (1973) 1.91

Lassa fever: review of epidemiology and epizootiology. Bull World Health Organ (1975) 1.86

Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets. Gastroenterology (1996) 1.84

Norwalk gastrointestinal illness: an outbreak associated with swimming in a recreational lake and secondary person-to-person transmission. Am J Epidemiol (1982) 1.81

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol (2000) 1.79

Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. JAMA (1990) 1.79

The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity. Bull World Health Organ (1973) 1.79

The Pathology of Malignant Catarrhal Fever (Bovine Epitheliosis): With Special Reference to Cytoplasmic Inclusions. Am J Pathol (1947) 1.73

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. J Virol (2001) 1.73

Lassa fever in Britain: an imported case. Br Med J (1973) 1.72

Gastroenteritis due to rotavirus in an isolated Pacific island group: an epidemic of 3,439 cases. J Infect Dis (1980) 1.65

St. Louis encephalitis virus infection in mice. Electron microscopic studies of central nervous system. Lab Invest (1968) 1.64

Lassa fever. Virological and serological studies. Trans R Soc Trop Med Hyg (1972) 1.60

Lassa fever and Marburg virus disease. WHO Chron (1974) 1.58

Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol (1990) 1.58

Challenge model for Helicobacter pylori infection in human volunteers. Gut (2004) 1.57

Characteristics of noncultivable adenoviruses associated with diarrhea in infants: a new subgroup of human adenoviruses. J Clin Microbiol (1979) 1.56

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology (1999) 1.56

Mode of entry of a neurotropic arbovirus into the central nervous system. Reinvestigation of an old controversy. Lab Invest (1983) 1.55

Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun (1998) 1.54

Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens. Infect Immun (1972) 1.53

The clinical consequences of a stiff left atrium. Am Heart J (1991) 1.52

Labile serum factor and its effect on arbovirus neutralization. Appl Microbiol (1971) 1.51

Detection of yellow fever virus in serum by enzyme immunoassay. Am J Trop Med Hyg (1984) 1.50

Gastroenteritis due to Norwalk virus: an outbreak associated with a municipal water system. J Infect Dis (1982) 1.49

Genetic variation among dengue 2 viruses of different geographic origin. Virology (1983) 1.48

Arthropod-borne encephalitides in the Americas. Bull World Health Organ (1979) 1.47

An outbreak of Norwalk gastroenteritis associated with swimming in a pool and secondary person-to-person transmission. Am J Epidemiol (1982) 1.47

Lupus-like presentation of human parvovirus B19 infection. J Rheumatol (1992) 1.46

An outbreak of acute nonbacterial gastroenteritis in a nursing home. Demonstration of person-to-person transmission by temporal clustering of cases. Am J Epidemiol (1982) 1.46

Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis (1992) 1.45

Neutralizing antibody responses in the major immunoglobulin classes to yellow fever 17D vaccination of humans. Am J Epidemiol (1971) 1.45

Antiviral (RNA) activity of selected Amaryllidaceae isoquinoline constituents and synthesis of related substances. J Nat Prod (1992) 1.43

Epidemic yellow fever caused by an incompetent mosquito vector. Trop Med Parasitol (1989) 1.43

Urban yellow fever epidemic in western Nigeria, 1987. Trans R Soc Trop Med Hyg (1990) 1.41

Norwalk virus gastroenteritis aboard a cruise ship: an outbreak on five consecutive cruises. Am J Epidemiol (1980) 1.40

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Virology (2002) 1.39

Variation in virulence for mice and rhesus monkeys among St. Louis encephalitis virus strains of different origin. Am J Trop Med Hyg (1980) 1.38

Reevaluation of the western equine encephalitis antigenic complex of alphaviruses (family Togaviridae) as determined by neutralization tests. Am J Trop Med Hyg (1988) 1.38

Vector-host studies of an epizootic of Venezuelan equine encephalomyelitis in Guatemala, 1969. Am J Epidemiol (1971) 1.37

Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun (1995) 1.35

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol (2001) 1.32

The use of Lassa fever convalescent plasma in Nigeria. Trans R Soc Trop Med Hyg (1984) 1.31

Recent isolations of Lassa virus from Nigerian rodents. Bull World Health Organ (1975) 1.31

Genetic heterogeneity of yellow fever virus strains from Africa and the Americas. J Gen Virol (1986) 1.30

Norwalk-related viral gastroenteritis due to contaminated drinking water. Am J Epidemiol (1981) 1.27

Variation among strains of St. Louis encephalitis virus: basis for a genetic, pathogenetic, and epidemiologic classification. Ann N Y Acad Sci (1980) 1.27

Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology (1997) 1.27

Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine (1997) 1.26

Production of specific varicella antiserum. Appl Microbiol (1968) 1.26

Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun (1999) 1.25

Yellow fever in the Gambia, 1978--1979: epidemiologic aspects with observations on the occurrence of orungo virus infections. Am J Trop Med Hyg (1980) 1.24

In vitro and in vivo properties of antimacrophage sera. J Immunol (1969) 1.23

Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun (2001) 1.23

Diarrheal illness among infants and toddlers in day care centers. I. Epidemiology and pathogens. J Pediatr (1985) 1.23

Laboratory transmission of eastern equine encephalomyelitis virus to chickens by chicken mites (Acari: Dermanyssidae). J Med Entomol (1993) 1.23

Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans R Soc Trop Med Hyg (1977) 1.22

Marburg virus. Ann N Y Acad Sci (1970) 1.22

Waterborne gastroenteritis due to the Norwalk agent: clinical and epidemiologic investigation. Am J Public Health (1982) 1.20

Geographic distribution and evolution of yellow fever viruses based on direct sequencing of genomic cDNA fragments. J Gen Virol (1994) 1.20

Foodborne Norwalk virus. Am J Epidemiol (1982) 1.19

Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods (1993) 1.19

Imported Lassa fever--reexamining the algorithms. N Engl J Med (1990) 1.18

Colorado tick fever virus: an electron microscopic study. Virology (1968) 1.17

Lassa virus hepatitis. Observations on a fatal case from the 1972 Sierra Leone epidemic. Arch Pathol (1975) 1.16

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting. Vaccine (1997) 1.16

[Sylvatic yellow fever in Africa recent advances and present approach (author's transl)]. Med Trop (Mars) (1981) 1.16

The ultrastructure of disrupted herpesvirus nucleocapsids. Virology (1975) 1.16

A field study on the effects of Fort Morgan virus, an arbovirus transmitted by swallow bugs, on the reproductive success of cliff swallows and symbiotic house sparrows in Morgan County, Colorado, 1976. Am J Trop Med Hyg (1984) 1.15

Detection of antibody to group B adult diarrhea rotaviruses in humans. J Clin Microbiol (1987) 1.14

Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I. J Biol Chem (1997) 1.14

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology (2001) 1.14

Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue. J Gen Virol (1988) 1.13